New drugs take aim at one of cancer’s deadliest mutations - nature.com

1. New drugs take aim at one of cancer’s deadliest mutations  nature.com
2. Setidegrasib in Advanced NSCLC and Pancreatic Cancer Harboring the KRAS p.G12D Variant  The ASCO Post
3. Breakthrough drugs could finally tackle deadliest ‘undruggable’ cancer mutation  The News International
4. Erika Hamilton on Advancing KRAS G12D Targeting in Lung and Pancreatic Cancer  Oncodaily
5. Florida Cancer Specialists & Research Institute Contributes to Phase 1 Study Demonstrating Antitumor Activity with First-in-Class KRAS-Targeted Therapy for Treatment of Lung and Pancreatic Cancers  PR Newswire